To the Editor: Adam1 contends that Roxanas and colleagues2 have overemphasised the risk of renal replacement therapy (RRT) associated with lithium treatment. I disagree.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Adam WR. Renal replacement therapy associated with lithium nephrotoxicity in Australia [letter]. Med J Aust 2014; 201: 30. <MJA full text>
- 2. Roxanas M, Grace BS, George CRP. Renal replacement therapy associated with lithium nephrotoxicity in Australia. Med J Aust 2014; 200: 226-228. <MJA full text>
- 3. Bendz H, Schon S, Attman P, Aurell M. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 2010; 77: 219-224.
- 4. Aiff H, Attman P-O, Aurell M, et al. End-stage renal disease associated with prophylactic lithium treatment. Eur Neuropsychopharmacol 2014; 24: 540-544.
- 5. Close H, Reilly J, Mason JM, et al. Renal failure in lithium-treated bipolar disorder: a retrospective cohort study. PLOS One 2014; 9: e90169. doi: 10.1371/journal.pone.0090169.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
No relevant disclosures.